Galocitabine

Get a Quick Quote Now
Select Packaging

Product Description
Product
Galocitabine
CAS
124012-42-6
Formula
C19H22FN3O8
Synonym
Galocitabine, 124012-42-6, Galocitabine [INN], Ro 09-1390, Ro-09-1390, X9788XI79O, N-(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-3,4,5-trimethoxybenzamide, Galocitabina, Galocitabinum, Galocitabinum [INN-Latin], Galocitabina [INN-Spanish], 5'-Deoxy-5-fluoro-N-(3,4,5-trimethoxybenzoyl)cytidine, UNII-X9788XI79O, N(4)-trimethoxybenzoyl-5'-deoxy-5-fluorocytidine, N(4)-trimethoxybenzoyl-5-fluoro-5'-deoxycytidine, SCHEMBL18876, GALOCITABINE [WHO-DD], CHEMBL2106813, DTXSID10154189, Cytidine, 5'-deoxy-5-fluoro-N-(3,4,5-trimethoxybenzoyl)-, N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]-3,4,5-trimethoxybenzamide, Q27293720, N-(1-(5-DEOXY-.BETA.-D-RIBOFURANOSYL)-5-FLUORO-1,2-DIHYDRO-2-OXO-4-PYRIMIDINYL)-3,4,5-TRIMETHOXYBENZAMIDE
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Chemical Structure

Notes
Galocitabine is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
Galocitabine

Product Description
Product
Galocitabine
CAS
124012-42-6
Formula
C19H22FN3O8
Synonym
Galocitabine, 124012-42-6, Galocitabine [INN], Ro 09-1390, Ro-09-1390, X9788XI79O, N-(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-3,4,5-trimethoxybenzamide, Galocitabina, Galocitabinum, Galocitabinum [INN-Latin], Galocitabina [INN-Spanish], 5'-Deoxy-5-fluoro-N-(3,4,5-trimethoxybenzoyl)cytidine, UNII-X9788XI79O, N(4)-trimethoxybenzoyl-5'-deoxy-5-fluorocytidine, N(4)-trimethoxybenzoyl-5-fluoro-5'-deoxycytidine, SCHEMBL18876, GALOCITABINE [WHO-DD], CHEMBL2106813, DTXSID10154189, Cytidine, 5'-deoxy-5-fluoro-N-(3,4,5-trimethoxybenzoyl)-, N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]-3,4,5-trimethoxybenzamide, Q27293720, N-(1-(5-DEOXY-.BETA.-D-RIBOFURANOSYL)-5-FLUORO-1,2-DIHYDRO-2-OXO-4-PYRIMIDINYL)-3,4,5-TRIMETHOXYBENZAMIDE
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Chemical Structure

Notes
Galocitabine is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry